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Background
The Baculovirus Expression Vector System (BEVS) is
increasingly used for protein production in both indus-
try and academia, and much work has been conducted
to improve this system. The baculovirus infection of an
insect cell sets up a sophisticated and complex series of
gene expression events that are very tightly temporally
regulated. The study of this system has progressed to
such an extent that many control elements, such as acti-
vators, enhancers, and promoters involved in this pro-
cess have been discovered and characterized to some
extent, as reviewed in [1]. These control elements can
be used to regulate the expression of heterologous
genes, in order to move beyond “brute force” expression
of large amounts of protein within insect cells. It enables
researchers to set up a pre-planned series of expression
events of multiple genes within one cell, and to essen-
tially “program” gene expression by modifying the bacu-
lovirus genome. While some groups have investigated
this, a systematic study of control elements and how
expression from a single gene affects expression from
other heterologous genes, has not been conducted thus
far. This study characterizes gene expression from sev-
eral baculovirus promoters for the production of pro-
teins and virus-like particles, and examines interaction
effects when promoters drive expression of genes at dif-
ferent times and at different levels.
Materials and Methods
Two sets of protein coding genes were investigated.
Both sets of constructs were arranged such that one
gene was always under the control of the very strong
polyhedron (polh) promoter, while the other gene was
under the control of the early ie1, late basic, gp64orv-
cath, or the very late p10 promoters. The first set of
proteins examined consisted of two easily traceable
fluorescent proteins requiring minimal post-translational
processing: the enhanced green fluorescent protein
(eGFP, herein referred to as GFP) and a red fluorescent
protein (DsRed2 herein referred to as RFP). The RFP
gene was always under the control of the polh promoter
while GFP was placed downstream of one of the other
five promoters [2].The second set of proteins studied
were fusions of influenza A virus proteins. More specifi-
cally, human influenza A/PR/8/34 hemagglutinin (HA)
and matrix (M1) proteins were fused to eGFP(HAGFP)
and DsRed2 (M1RFP) respectively. The M1RFP gene
was always under the control of the polh promoter
while HAGFP was placed downstream of one of the
other five promoters.
Sf9 cells were infected at a cell density of 1 × 106
cells/mL and at a multiplicity of infection of 5. Cells
were examined by light and fluorescence microscopy, as
well as by flow cytometry. Virus-like particles were
recovered from infected cell culture supernatants by
subjecting the supernatants to iodixanol gradient ultra-
centrifugation as previously described in [3]. Virus-like
particles were characterized by flow cytometry using a
method similar to that described in [4],by negative stain
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transmission electron microscopy (TEM) and by multi-
angle dynamic light scattering (MADLS).
Results
By keeping the RFP gene under the control of the polh
promoter and varying the promoter in front of the GFP
gene, the effect of the expression of one protein on
another was established. As hypothesized by us and
alluded to by others, high expression levels of one pro-
tein (GFP) results in lower levels of the other (RFP),
with the exception of GFP driven by the ie1 promoter,
which resulted in lower than anticipated levels of RFP.
These findings are now allowing the development of
mathematical models with promoter specific parameters.
Compared to the production of GFP and RFP driven
by various baculovirus promoters upon infection of
insect cells, levels of fluorescence in cells infected with
baculovirus carrying the fluorescent influenza protein
fusion genes, under the control of the same promoter
combinations, were very similar. This was true despite
the fusion proteins having completely different localiza-
tion in the cell. While GFP and RFP ‘flooded’ the cell to
create cells with uniform fluorescence (Figure 1A), the
fusion proteins had distinct localization. HAGFP,
Figure 1 (a) Uniform fluorescence in cells infected with baculovirus carrying GFP and RFP under two different promoters. (b) Localized
protein expression in cells infected with baculovirus carrying HAGFP and M1RFP under two different promoters. (c) Smoothed flow cytometry
scatterplots of iodixanol gradient purified VLP samples. Left scatterplot is the analysis of material recovered from the supernatant of insect cell
cultures infected with a baculovirus having the HAGFP gene under the control of the p10 promoter and M1RFP under the control of the polh
promoter. Right scatterplot is the analysis of material recovered from the supernatant of insect cell cultures infected with a baculovirus having the
HAGFP gene under the control of the vcath promoter and M1RFP under the control of the polh promoter. (d) TEM image of VLPs produced from
cells infected with a baculovirus having the HAGFP gene under the control of the p10 promoter and M1RFP under the control of the polh promoter.
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localized uniquely to the cell membrane while M1RFP
first localized near the center of the cell before also
localizing at the cell membrane (Figure 1B).
Unlike the original model system consisting of GFP and
RFP, the goal of making the influenza protein fusion con-
structs was the development of a system that would lead
to fluorescent virus-like particles. Given the very similar
fluorescent time-course profiles of the cells, there were no
immediate indicators of VLP budding. Iodixanol gradient
ultracentrifugation of the supernatants was able to isolate
VLPs of approximately 70-85 nm having the distinct
spike-like projections of influenza particles (Figure 1D).
Iodixanol purified VLPs subjected to analysis by flow cyto-
metry revealed different red and green fluorescent levels
corresponding to the choice of baculovirus vector and
promoter control used for the generation of the particles
(Figure 1C).
Conclusions
This work shows that promoter control is achievable in
a system producing simple proteins, as well as in one
producing complex protein structures such as virus-like
particles. Characterization of outcomes from the use of
promoter control is leading to more robust, fine-tunable
and predictable protein expression. To our knowledge,
this work is the first instance where the complete HA
protein has been fused to a fluorescent protein, and the
first report of fluorescently tagged HA and M1 proteins
co-localizing into a single particle, which can be tracked
by flow cytometry. Finally, it has been shown that tai-
lored protein expression can also modulate the composi-
tion of virus-like particles.
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